🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

One of the perks of being a scientist is to travel to beautiful places like Paris and to hear about great science Global Hepatitis Summit . Don’t miss Basic Science session on Biology of Flaviviruses this afternoon!!

Congrats Jordan Feld . Well deserved indeed👏

Would you participate in a controlled human infection trial to test new HCV vaccines? You can find out about the ethical, clinical, virologic and immunological consideration at this Web Symposium on Thursday. Don't miss it!!

Find out more about Controlled Human Infection Model for HCV Vaccine Development by reading this series of articles in CID by leading researchers in the field. academic.oup.com/cid/issue/77/S…

New Correspondence - Alter et al, on behalf of 121 signatories - Joint statement in support of hepatitis C human challenge studies thelancet.com/journals/langa… #NoHep #HepC #LiverTwitter #MedTwitter 1Day Sooner #HCV #CHIM

📢CanHepC is #hiring a new Curriculum Process Lead to oversee the management of our Training program and annual Symposium. 👩‍🎓👨‍🎓 Come and join a wonderful team of dedicated researchers and students! Follow this 🔗to apply : rb.gy/5hr6uj

Nice reunion with Labo Shoukry Alumni at Immunology2014 in Chicago MoSalah A-Hakeem * (محمد صلاح (بتاع المناعة Thomas Fabre

Today @Immunology2024, come see our poster B226 (at 2:15 -3:30) by talented Postdoctoral Afrooz Dabbaghizadeh about how inhibiting the IL17 pathway can treat liver fibrosis

À Ottawa 🇨🇦 aujourd'hui pour #CanHepDay24 afin de tenir les gouvernements responsables de leur engagement à éliminer l'#hépatite virale en tant que menace pour la santé publique d'ici 2030! 📢Voici les demandes que nous ferons au gouvernement fédéral : canhepc.ca/fr/nouvelles/9…

Our latest publication showing coordinated T and B cell responses during spontaneous clearance of HCV re- reinfection suggesting that both arms of the immune response are critical for long-term protective immunity against HCV. Centre de recherche du CHUM CanHepC Network CIHR frontiersin.org/journals/immun…

Happy to share our publication Hepatology Communications showing the dual role of neutrophils during acute liver injury. Early wave is inflammatory while the late wave is pro-repair journals.lww.com/hepcomm/fullte…

Excited to share our new review article on type 3 cytokines during MASLD CanHepC Network CanHepCTrainees Mohamed frontiersin.org/journals/immun…

Excited to hear great science @HcvFlavi2024 .

Come see great scientific posters from our group @HcvFlavi2024 by Elsa Gomez Nicol Flores Nourtan and Mohamed Eisa

Great group of CanHepC Network investigators &@CanHepCtrainee @HcvFlavi2024 presenting their exciting research

Tomorrow @HcvFlavi2024 do not miss oral presentation by Samaa Gobran about how HCV-specific CD4 T cells feed the HIV reservoir

Our new article optimizing Activation-Induced Marker Assay to Identify and Isolate HCV-Specific CD4 and CD8 T Cells from t he same sample for Single-Cell RNA-Seq Analysis mdpi.com/3000598 #mdpiviruses via Viruses MDPI Centre de recherche du CHUM CanHepC Network Nicol Flores Elsa Gomez Nourtan

Proud of my former trainee and current Pfizer Senior Scientist Thomas Fabre for an excellent talk about making sense of the myeloid mess #Aegean Fibrosis Confirmed

IL21-expressing CXCR5− PD1+ CD4 T cells accumulate, acquire memory and home to tissues in severe dengue, driving humoral response in extrafollicular niche Cell Reports cell.com/cell-reports/f… Nimesh Gupta Preview Naglaa Shoukry cell.com/cell-reports/f…

New data from Naglaa Shoukry at Centre de recherche du CHUM found that treating mice with the RORγt inhibitors TF-S10 and TF-S14 improved the appearance and function of the liver. These results open the door for new therapeutics to treat #LiverFibrosis. Read more in #AAINews ow.ly/uhG350W6VRu